Treating Hepatitis C Virus Infection
Hepatitis C virus (HCV) infection is a disease that causes liver inflammation. The hepatitis C virus is extremely contagious. While some cases of hepatitis C virus infection are acute (short-term), most patients have long-lasting (chronic) cases. The Centers for Disease Control and Prevention (CDC) estimates that up to 85 percent of people infected with HCV develop chronic disease. If you have HCV infection, genetic testing will help your doctor find the right treatment because the treatments are very specific.In the last year or two new treatments for HCV infection have become available. These treatments have been much more successful at treating the disease. Additionally, many treatments are currently in development. Some treatments can cure HCV infection, so it’s important to work closely with your doctor to select the best treatment.
Medications to treat HCV infection
are essential for:
- preventing liver disease (cirrhosis)
- relieving symptoms
- decreasing the risk for liver cancer
- preventing liver failure
Interferons
Interferons are proteins that are usually present in the body. They help fight infections. Interferon medications help the immune system fight off the HCV to prevent complications. These include:- peginterferon alfa-2a (Pegasys)
- peginterferon alfa-2b (PegIntron, Sylatron)
- interferon alfa-2b (Intron A)
Here is a breakdown of dosage
information:
The most common side effects are:
- The recommended dose for peginterferon alfa-2a is 180-mcg shots per week. It may be given to people aged 5 years and older.
- The recommended peginterferon alfa-2b dosage for treatment of severe HCV is 3 mcg per week for 8 weeks and then 1.5 mcg per week for five years. These injections may be given to people aged 3 years and older.
- Interferon alfa-2b is given in shots of 3 million units, three times per week. These injections may be given to people aged 1 year and older. Interferon alfa-2b has more intense side effects, so it’s not often used.
- anxiety
- dry mouth
- excessive fatigue
- headache
- mood changes
- weight loss
- worsening hepatitis symptoms
Protease Inhibitor Antiviral Medications
Protease inhibitors are oral medications that work by preventing the spread of infection. They stop viruses from multiplying in the body. Protease inhibitors for HCV infection include:- telaprevir (Incivek)
- boceprevir (Victrelis)
- paritaprevir (This is a protease inhibitor but it’s only available within the Viekira Pak, as part of a combination used to treat HCV infection.)
The most common side effects are:
- anemia
- diarrhea
- fatigue
- headaches
- nausea
- vomiting
Nucleoside Analogue Antiviral Medications
Nucleoside analogue antiviral medications also prevent viruses from spreading. This class of drugs stops nucleosides from forming in infected cells. Ribavirin is the type of nucleoside analogue used to treat HCV infection.Ribavirin is most commonly used with an interferon to treat HCV infection. In some cases, it may also be used as a triple therapy with an interferon and a protease inhibitor. Like interferons and protease inhibitors, ribavirin is not a stand-alone treatment for HCV infection.
Ribavirin is available in several dose forms and strengths. Various forms include capsules, tablets, and oral solution. All of these forms are not available in every brand. Brands names of ribavirin include:
- Copegus
- Moderiba
- Rebetol
- Ribasphere
- Ribasphere RibaPak
- Virazole
Polymerase Inhibitor and Combination Drug Treatments
Aside from ribavirin, there are newer types of nucleoside analogues available on the market. These include the polymerase inhibitor sovaldi (Sofosbuvir). Sovaldi works by inhibiting the RNA polymerase that the hepatitis C virus uses to replicate its RNA. This means it prevents the building blocks of the hepatitis C virus from coming together.
Sovaldi is available in a 400-mg
oral tablet, taken once per day. Sovaldi is sometimes used in conjunction with
ribavirin for up to 24 weeks. It also may be used to treat people with both
hepatitis C virus infection and HIV infection.
The combination drug of ledipasvir and sofosbuvir (Harvoni) is used to treat chronic infection with HCV genotype 1 in adults. Ledipasvir is a NS5A inhibitor. It blocks the formation of a protein that helps the virus copy itself. Sofosbuvir is a polymerase inhibitor. It prevents the building blocks of the virus from coming together.
Harvoni is available as a film coated tablet in one strength: 90 mg of ledipasvir and 400 mg of sofosbuvir. The usual dose is one tablet, taken once per day, for 12-24 weeks, depending on whether or not cirrhosis is present.
Viekira Pak includes 28 tablets of the combination drug of ombitasvir (12.5 mg), paritaprevir (75 mg), and ritonavir (50 mg) and 28 tablets of dasabuvir (250 mg) in a single packet (56 tablets total). Ombitasvir is a NS5A inhibitor. It blocks the formation of a protein that helps the virus copy itself. Paritaprevir is a protease inhibitor, which helps stop the building of small pieces that make up the virus. Dasabuvir is a polymerase inhibitor. It prevents the building blocks of the virus from coming together. Ritonavir does not attack hepatitis. It helps increase the effectiveness of paritaprevir by making it last longer in your body.
The usual dose is two tablets of ombitasvir/paritaprevir/ritonavir every morning for 12 to 24 weeks, and one 250 mg tablet of dasabuvir twice a day for 12 to 24 weeks. Your doctor will decide the length of treatment.
These drugs should be taken with a meal and shouldn’t be crushed.
The side effects of this drug combination include:
The combination drug of ledipasvir and sofosbuvir (Harvoni) is used to treat chronic infection with HCV genotype 1 in adults. Ledipasvir is a NS5A inhibitor. It blocks the formation of a protein that helps the virus copy itself. Sofosbuvir is a polymerase inhibitor. It prevents the building blocks of the virus from coming together.
Harvoni is available as a film coated tablet in one strength: 90 mg of ledipasvir and 400 mg of sofosbuvir. The usual dose is one tablet, taken once per day, for 12-24 weeks, depending on whether or not cirrhosis is present.
Viekira Pak includes 28 tablets of the combination drug of ombitasvir (12.5 mg), paritaprevir (75 mg), and ritonavir (50 mg) and 28 tablets of dasabuvir (250 mg) in a single packet (56 tablets total). Ombitasvir is a NS5A inhibitor. It blocks the formation of a protein that helps the virus copy itself. Paritaprevir is a protease inhibitor, which helps stop the building of small pieces that make up the virus. Dasabuvir is a polymerase inhibitor. It prevents the building blocks of the virus from coming together. Ritonavir does not attack hepatitis. It helps increase the effectiveness of paritaprevir by making it last longer in your body.
The usual dose is two tablets of ombitasvir/paritaprevir/ritonavir every morning for 12 to 24 weeks, and one 250 mg tablet of dasabuvir twice a day for 12 to 24 weeks. Your doctor will decide the length of treatment.
These drugs should be taken with a meal and shouldn’t be crushed.
The side effects of this drug combination include:
- nausea
- itching
- insomnia
- weakness
Alternative Medicine
Some people with HCV infection wish to explore the possibility of alternative medicine for treatment. This is in part due to a desire to not have side effects. According to the National Center for Complementary and Alternative Medicine (NCCAM), there are currently no supplements that have proven to effectively treat HCV infection. At the same time, some studies have been conducted on select herbs. You should not take an herbal treatment in place of your medication or without speaking to your doctor first. Herbs can be just as powerful as conventional drugs in causing interactions.Licorice Root
Licorice root is indigenous to parts of Asia and the Middle East. Historically, the herb is used for infections, ulcers, and bronchitis. Licorice root is available in numerous forms, including:- capsules
- dried powder
- liquid extracts
- tablets
Milk Thistle
Milk thistle comes from a Mediterranean plant. It’s sometimes used as a folk remedy for:- cancer
- diabetes
- hepatitis
- high cholesterol
- liver disease
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.